A class-action lawsuit against the makers of Cold-FX has revealed that they had the results of a study that slammed the remedy’s effectiveness, but did nothing about it.
A 2004 trial conducted by Dr. Gerry Predy, a top Alberta public-health official, found that one of Canada’s most well-known cold and flu remedies was no better than a placebo when it came to treating symptoms.
Cold-FX has long argued that their product brings quick and fast relief from the worst parts of the common ailments that plague mankind.
Neither Predy nor Afexa Life Sciences (which was purchased by Valeant Pharmaceuticals in 2011) publicly revealed the results.
Lawyer John Green, who is spearheading a class action lawsuit against Valeant, felt that “if it had been disclosed, it would probably have been the end of Afexa Life Sciences.”
In Canada, companies are not legally obliged to release the results of trials.
Listen live on AM640, online at: player.640toronto.com, or download the AM640 app from the Apple App Store or Google Play.